Merrion Investment Management Co, LLC

Position in NVO — Novo Nordisk A S

CIK 1383782 Cranford, NJ

Position in NVO

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$937,946

New position

Shares Held

19,565

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#542

of 1,348 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Merrion Investment Management Co, LLC holds $7,672,732 across 6 Drug Manufacturers - General names. NVO ranks #4 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	8,864	$2,251,190
2	LLY	ELI LILLY & Co	1,550	$1,859,116
3	ABBV	AbbVie Inc.	7,000	$1,761,480
4	NVO	Novo Nordisk A S This page	19,565	$937,946
5	AMGN	Amgen Inc	1,483	$537,023
6	NVS	Novartis AG	2,080	$325,977

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$937,946	19,565	—	Shares	Sole	2026-07-13
No filing history on record for this holder in this stock.